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hypothermes à la 60e min d’OC (~32°C). Les tailles d’infarctus et 
de “no re ow” étaient signi cativement réduites dans les groupes 
VLT et VLT20min, mais pas dans le groupe RE par rapport au groupe 
Témoin.
Conclusion — L’hypothermie induite par ventilation liquide 
totale permet d’induire une cardioprotection persistante après 
60 min d’occlusion coronaire chez le lapin, à savoir dans le cas 
d’un infarctus massif et quasi-transmural. Un refroidissement 
externe s’avère inef cace dans ces conditions malgré l’atteinte 
d’une même température cible au moment de la reperfusion. Ces 
données renforcent l’intérêt d’une hypothermie ultra-rapide au 
cours du processus ischémique.
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Purpose — Heart rate reduction by the selective If current inhibitor 
ivabradine improves systolic cardiac function in experimental 
congestive heart failure. Here, we investigated whether its 
administration would be also bene cial in early post-infarction 
remodelling following ischemia-reperfusion and particularly at the 
level of the contractile function of the viable reperfused area.
Methods — Rabbits were submitted to 20 min of coronary 
artery occlusion (CAO). Throughout the subsequent 3 weeks of 
reperfusion, they received continuous infusion of either ivabradine 
(10 mg/kg/day, n=8) or vehicle (control, n=9) using implanted 
osmotic pumps. Global and regional systolic functions were 
assessed by echocardiography and tissue tracking imaging (TTI) 
(Vingmed System 7), respectively, at baseline (1 week before CAO) 
and throughout the 3 weeks of reperfusion. TTI was performed in 
the left ventricular (LV) free wall within the territory subjected to 
ischemia-reperfusion.
Results — Throughout the 3 weeks of reperfusion, ivabradine 
signi cantly and constantly reduced heart rate (~-20 %) (Table). 
Ejection fraction and regional systolic displacement assessed by 
TTI were signi cantly improved in ivabradine vs vehicle groups 
(e.g. +35 % and +36 % at Day 21, respectively). Post-mortem analyses 
revealed that the area subjected to ischemia was similar in both 
groups (29±2 and 29±3 % of LV, respectively). This area consisted 
into a thin infarcted scar (7±1 and 9±2 % of LV, respectively) 
surrounded by salvaged myocardium and  brosis.
Conclusion — Heart rate reduction induced by ivabradine improves 
global systolic function in the post-infarction period and moreover 
improves the regional contractility of the remodelled myocardium 
salvaged by reperfusion. These bene ts suggest the potential 
interest of ivabradine in the management of post-infarcted 
myocardial dysfunction.
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Coronary heart disease is frequently associated with obstructive 
sleep apnea syndrome and treating obstructive sleep apnea 
appears to signi cantly improve the outcome in coronary heart 
disease. We have previously shown in the rat that chronic 
intermittent hypoxia increases heart sensitivity to infarction. In 
this study, deleterious mechanisms potentially involved in this 
IH-induced infarction aggravation were explored using the anti-
ischemic drug trimetazidine (TMZ), and a free radical scavenger 
Tempol, investigating the role of oxidative stress, and myocardial 
vascularization.
Wistar male rats were divided in two experimental groups subjected 
to chronic IH (IH group) or normoxia (N group). IH consisted of 
repetitive cycles of 1 min (40 s with inspired O2 fraction 5 % followed 
by 20 s normoxia) and was applied for 8 h during daytime, for 14 or 35 
days. Normoxic cycles were applied in the same conditions, inspired 
O2 fraction remaining constant at 21 %. After the 14-day exposure, 
mean arterial blood pressure (MABP) was measured. Isolated hearts 
were then submitted to an ischemia-reperfusion protocol at the end 
of which infarct size were measured.
MABP was signi cantly increased in IH group compared to N 
group. Infarct sizes (expressed in percent of ventricle’s area) 
were signi cantly higher in IH group (34.0 ± 2.8 %) compared 
with N group (21.8 ± 3.1 %). Tempol (1 mM administered in water 
during the 14-day exposure) prevented this deleterious effect 
since infarction was comparable between IH (24.8 ± 2.8 %) 
and N (27.9 ± 4.0 %) groups. Moreover, Tempol also prevented 
the IH-induced increase in MABP after the 14-day exposure. 
Trimetazidine (10 mg/day administered in food during the 14-day 
exposure) did not prevent the IH-induced infarction aggravation 
(40.1 ± 3.6 % in IH+TMZ group signi cantly higher than 29.1 ± 
2.9 % in N+TMZ group) and has no effect on IH-induced increase 
in MABP. After a 35-day exposure, IH signi cantly increased 
ventricular vascular density and VEGF expression.
